Iodide manipulation using zinc additives for efficient perovskite solar minimodules.

Interstitial iodides are the most critical type of defects in perovskite solar cells that limits efficiency and stability. They can be generated during solution, film, and device processing, further accelerating degradation. Herein, we find that introducing a small amount of a zinc salt- zinc trifluoromethane sulfonate (Zn(OOSCF3)2) in the perovskite solution can control the iodide defects in resultant perovskites ink and films. CF3SOO̶ vigorously suppresses molecular iodine formation in the perovskites by reducing it to iodide. At the same time, zinc cations can precipitate excess iodide by forming a Zn-Amine complex so that the iodide interstitials in the resultant perovskite films can be suppressed. The perovskite films using these additives show improved photoluminescence quantum efficiency and reduce deep trap density, despite zinc cations reducing the perovskite grain size and iodide interstitials. The zinc additives facilitate the formation of more uniform perovskite films on large-area substrates (78-108 cm2) in the blade-coating process. Fabricated minimodules show power conversion efficiencies of 19.60% and 19.21% with aperture areas of 84 and 108 cm2, respectively, as certified by National Renewable Energy Laboratory (NREL), the highest efficiency certified for minimodules of these sizes.

Influence of Goniotomy Size on Treatment Safety and Efficacy for Primary Open-Angle Glaucoma: A Multicenter Study.

PURPOSE: To compare the efficacy and safety of 120-, 240-, and 360-degree goniotomy (GT) with or without phacoemulsification with intraocular lens implantation (PEI) for patients with primary open-angle glaucoma (POAG). DESIGN: Multicenter, retrospective, comparative, nonrandomized interventional study. METHODS: Patients diagnosed with POAG who underwent GT with or without PEI were included, and divided into 6 groups: 1) standalone 120-degree GT (120GT); 2) standalone 240-degree GT (240GT); 3) standalone 360-degree GT (360GT); 4) PEI + 120GT; 5) PEI + 240GT; and 6) PEI + 360GT. Data on intraocular pressure (IOP), the number of ocular hypotensive medications, and complications were collected and compared. Success was defined as a postoperative IOP within the range of 6 to 18 mm Hg and a 20% reduction from baseline without further glaucoma surgery. Complete success and qualified success were defined as the above without and with ocular hypotensive medications, respectively. RESULTS: Three hundred eight eyes of 231 patients were included with a mean follow-up of 14.4 ± 8.6 months (6.0-48.0 months). There were no significant differences in the reductions in IOP and number of medications and cumulative survival probability for complete and qualified success rates among the 3 groups of standalone GT and PEI + GT. The 360GT group had the highest proportion of hyphema with or without PEI. CONCLUSIONS: 120GT, 240GT, and 360GT with or without PEI showed similar efficacy in reducing IOP and medications used in POAG. 360GT with or without PEI was more likely to cause hyphema compared with 120GT or 240GT. 120GT with or without PEI was sufficient for treating POAG with or without cataract..

Controllable Heterogenous Seeding-Induced Crystallization for High-Efficiency FAPbI3 -Based Perovskite Solar Cells Over 24.

The addition of small seeding particles into a supersaturated solution is one among the most effective approaches to obtain high-quality semiconductor materials via increased crystallization rates. However, limited study is conducted on this approach for the fabrication of perovskite solar cells. Here, a new strategy-"heterogenous seeding-induced crystallization (hetero-SiC)" to assist the growth of FAPbI3 -based perovskite is proposed. In this work, di-tert-butyl(methyl)phosphonium tetrafluoroborate is directly introduced into the precursor, which forms a low-solubility complex with PbI2 . The low-solubility complex can serve as the seed to induce crystallization of the perovskite during the solvent-evaporation process. Various in situ measurement tools are used to visualize the hetero-SiC process, which is shown to be an effective way of manipulating the nucleation and crystal growth of perovskites. The hetero-SiC process greatly improves the film quality, reduces film defects, and suppresses nonradiative recombination. A hetero-SIC proof-of-concept device exhibits outstanding performance with 24.0% power conversion efficiency (PCE), well over the control device with 22.2% PCE. Additionally, hetero-SiC perovskite solar cell (PSC) stability under light illumination is enhanced and the PSC retains 84% of its initial performance after 1400 h of light illumination.

Room-temperature multiple ligands-tailored SnO2 quantum dots endow in situ dual-interface binding for upscaling efficient perovskite photovoltaics with high VOC.

The benchmark tin oxide (SnO2) electron transporting layers (ETLs) have enabled remarkable progress in planar perovskite solar cell (PSCs). However, the energy loss is still a challenge due to the lack of "hidden interface" control. We report a novel ligand-tailored ultrafine SnO2 quantum dots (QDs) via a facile rapid room temperature synthesis. Importantly, the ligand-tailored SnO2 QDs ETL with multi-functional terminal groups in situ refines the buried interfaces with both the perovskite and transparent electrode via enhanced interface binding and perovskite passivation. These novel ETLs induce synergistic effects of physical and chemical interfacial modulation and preferred perovskite crystallization-directing, delivering reduced interface defects, suppressed non-radiative recombination and elongated charge carrier lifetime. Power conversion efficiency (PCE) of 23.02% (0.04 cm2) and 21.6% (0.98 cm2, VOC loss: 0.336 V) have been achieved for the blade-coated PSCs (1.54 eV Eg) with our new ETLs, representing a record for SnO2 based blade-coated PSCs. Moreover, a substantially enhanced PCE (VOC) from 20.4% (1.15 V) to 22.8% (1.24 V, 90 mV higher VOC, 0.04 cm2 device) in the blade-coated 1.61 eV PSCs system, via replacing the benchmark commercial colloidal SnO2 with our new ETLs.

Multifunctional Crosslinking-Enabled Strain-Regulating Crystallization for Stable, Efficient α-FAPbI3 -Based Perovskite Solar Cells.

α-Formamidinium lead triiodide (α-FAPbI3 ) represents the state-of-the-art for perovskite solar cells (PSCs) but experiences intrinsic thermally induced tensile strain due to a higher phase-converting temperature, which is a critical instability factor. An in situ crosslinking-enabled strain-regulating crystallization (CSRC) method with trimethylolpropane triacrylate (TMTA) is introduced to precisely regulate the top section of perovskite film where the largest lattice distortion occurs. In CSRC, crosslinking provides in situ perovskite thermal-expansion confinement and strain regulation during the annealing crystallization process, which is proven to be much more effective than the conventional strain-compensation (post-treatment) method. Moreover, CSRC with TMTA successfully achieves multifunctionality simultaneously: the regulation of tensile strain, perovskite defects passivation with an enhanced open-circuit voltage (VOC  = 50 mV), and enlarged perovskite grain size. The CSRC approach gives significantly enhanced power conversion efficiency (PCE) of 22.39% in α-FAPbI3 -based PSC versus 20.29% in the control case. More importantly, the control PSCs' instability factor-residual tensile strain-is regulated into compression strain in the CSRC perovskite film through TMTA crosslinking, resulting in not only the best PCE but also outstanding device stability in both long-term storage (over 4000 h with 95% of initial PCE) and light soaking (1248 h with 80% of initial PCE) conditions.

Bottom-Up Quasi-Epitaxial Growth of Hybrid Perovskite from Solution Process-Achieving High-Efficiency Solar Cells via Template​-Guided Crystallization.

Epitaxial growth gives the highest-quality crystalline semiconductor thin films for optoelectronic devices. Here, a universal solution-processed bottom-up quasi-epitaxial growth of highly oriented α-formamidinium lead triiodide (α-FAPbI3 ) perovskite film via a two-step method is reported, in which the crystal orientation of α-FAPbI3 film is precisely controlled through the synergetic effect of methylammonium chloride and the large-organic cation butylammonium bromide. In situ GIWAXS visualizes the BA-related intermediate phase formation at the bottom of film, which serves as a guiding template for the bottom-up quasi-epitaxial growth in the subsequent annealing process. The template-guided epitaxially grown BAFAMA perovskite film exhibits increased crystallinity, preferred crystallographic orientation, and reduced defects. Moreover, the BAFAMA perovskite solar cells demonstrate decent stability, maintaining 95% of their initial power conversion efficiency after 2600 h ambient storage, and 4-time operation condition lifetime enhancement.

Precise Control of Perovskite Crystallization Kinetics via Sequential A-Site Doping.

Two-step-fabricated FAPbI3 -based perovskites have attracted increasing attention because of their excellent film quality and reproducibility. However, the underlying film formation mechanism remains mysterious. Here, the crystallization kinetics of a benchmark FAPbI3 -based perovskite film with sequential A-site doping of Cs+ and GA+ is revealed by in situ X-ray scattering and first-principles calculations. Incorporating Cs+ in the first step induces an alternative pathway from δ-CsPbI3 to perovskite α-phase, which is energetically more favorable than the conventional pathways from PbI2 . However, pinholes are formed due to the nonuniform nucleation with sparse δ-CsPbI3 crystals. Fortunately, incorporating GA+ in the second step can not only promote the phase transition from δ-CsPbI3 to the perovskite α-phase, but also eliminate pinholes via Ostwald ripening and enhanced grain boundary migration, thus boosting efficiencies of perovskite solar cells over 23%. This work demonstrates the unprecedented advantage of the two-step process over the one-step process, allowing a precise control of the perovskite crystallization kinetics by decoupling the crystal nucleation and growth process.